Ogston A, 1882, J Anat, 17, 24
10.1056/NEJM198905043201806
10.1056/NEJM198405243102107
Wilkinson BJ, Biology. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997:1-38.
Schaberg DR, 1986, Antimicrob Agents Chemother, 30, 817, 10.1128/AAC.30.6.817
10.1016/0966-842X(96)10021-4
10.1111/j.1574-6968.1994.tb06828.x
10.1146/annurev.mi.48.100194.003101
Bhakdi S, 1991, Microbiol Rev, 55, 733, 10.1128/MMBR.55.4.733-751.1991
Walev I, 1995, EMBO J, 14, 1607, 10.1002/j.1460-2075.1995.tb07149.x
Harris TO, 1993, Infect Immun, 61, 3175, 10.1128/IAI.61.8.3175-3183.1993
Peng HL, 1988, J Bacteriol, 170, 4365, 10.1128/jb.170.9.4365-4372.1988
10.1017/S002217240004609X
10.1093/clinids/19.6.1123
10.1016/0195-6701(95)90079-9
10.1056/NEJM198607103150204
10.1056/NEJM195906252602601
Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995:1754-77.
Sheretz RJ, 1996, Ann Intern Med, 124, 539, 10.7326/0003-4819-124-6-199603150-00001
10.1016/0002-9343(91)90349-3
Emori TG, 1993, Clin Microbiol Rev, 6, 428, 10.1128/CMR.6.4.428
10.1016/S0140-6736(97)12148-1
10.1093/clinids/21.5.1308
Sanches IS, 1995, J Clin Microbiol, 33, 1243, 10.1128/JCM.33.5.1243-1246.1995
Dominguez MA, 1994, J Clin Microbiol, 32, 2081, 10.1128/JCM.32.9.2081-2087.1994
Foster TJ, Hartford O, O'Donnell D. Host–pathogen protein–protein interactions in Staphylococcus. In: McCrae MA, Saunders JR, Smyth CJ, Stow ND, eds. Molecular aspects of host–pathogen interaction. Cambridge, England: Cambridge University Press, 1997:67-94.
Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997.
Sanford BA, 1989, Proc Soc Exp Biol Med, 191, 163, 10.3181/00379727-191-42903
Shuter J, 1996, Infect Immun, 64, 310, 10.1128/IAI.64.1.310-318.1996
Elek SD, 1957, Br J Exp Pathol, 38, 573
10.1093/infdis/161.6.1177
Vercellotti GM, 1984, J Lab Clin Med, 103, 34
Ogawa SK, 1985, Infect Immun, 50, 218, 10.1128/IAI.50.1.218-224.1985
10.1016/S0889-1605(88)80906-6
Hamill RJ, 1986, Infect Immun, 54, 833, 10.1128/IAI.54.3.833-836.1986
Wu T, 1994, Antimicrob Agents Chemother, 38, 729, 10.1128/AAC.38.4.729
10.1002/(SICI)1097-4652(199710)173:1<102::AID-JCP12>3.0.CO;2-K
Ing MB, Baddour LM, Bayer AS. Bacteremia and infective endocarditis: pathogenesis, diagnosis, and complications. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997:331-54.
Patti JM, 1994, Infect Immun, 62, 152, 10.1128/IAI.62.1.152-161.1994
Timmerman CP, 1993, Infect Immun, 61, 4167, 10.1128/IAI.61.10.4167-4172.1993
Heumann D, 1994, Infect Immun, 62, 2715, 10.1128/IAI.62.7.2715-2721.1994
Yao L, 1995, Infect Immun, 63, 1835, 10.1128/IAI.63.5.1835-1839.1995
10.1001/archinte.154.1.26
10.3109/10408419009105728
Verdrengh M, 1997, Infect Immun, 65, 2517, 10.1128/IAI.65.7.2517-2521.1997
Yao L, 1997, Infect Immun, 65, 3889, 10.1128/IAI.65.9.3889-3895.1997
Beekhuizen H, 1997, J Immunol, 158, 774, 10.4049/jimmunol.158.2.774
Verdrengh M, 1996, Infect Immun, 64, 2804, 10.1128/IAI.64.7.2804-2807.1996
Karakawa WW, 1988, Infect Immun, 56, 1090, 10.1128/IAI.56.5.1090-1095.1988
Wergeland HI, 1989, J Clin Microbiol, 27, 1286, 10.1128/JCM.27.6.1286-1291.1989
Freedman JD, 1991, Adv Intern Med, 36, 363
10.1097/00005792-199407000-00002
10.1001/archinte.150.6.1305
10.1001/archinte.144.3.541
Jernigan JA, 1993, Ann Intern Med, 119, 304, 10.7326/0003-4819-119-4-199308150-00010
10.1001/archinte.146.6.1118
10.1016/S0735-1097(97)00250-7
Chambers HF, 1983, Medicine (Baltimore), 62, 170, 10.1097/00005792-198305000-00004
Marantz PR, 1987, Ann Intern Med, 106, 823, 10.7326/0003-4819-106-6-823
Fang G, 1993, Ann Intern Med, 119, 560, 10.7326/0003-4819-119-7_Part_1-199310010-00003
Casey LC, 1993, Ann Intern Med, 119, 771, 10.7326/0003-4819-119-8-199310150-00001
Chambers HF, 1997, Clin Microbiol Rev, 10, 781, 10.1128/CMR.10.4.781
10.1016/0966-842X(94)90608-4
Musser JM, 1992, J Clin Microbiol, 30, 2058, 10.1128/JCM.30.8.2058-2063.1992
10.1056/NEJM198704093161507
10.1111/j.1574-6968.1992.tb05089.x
1997, MMWR Morb Mortal Wkly Rep, 46, 813
Sieradzki K, 1997, J Bacteriol, 179, 2557, 10.1128/jb.179.8.2557-2566.1997
Tenover FC, 1998, J Clin Microbiol, 36, 1020, 10.1128/JCM.36.4.1020-1027.1998
Levine DP, 1991, Ann Intern Med, 115, 674, 10.7326/0003-4819-115-9-674
Karchmer AW, 1991, Ann Intern Med, 115, 739, 10.7326/0003-4819-115-9-739
10.1016/S0140-6736(96)11192-2
Trucksis M, 1991, Ann Intern Med, 114, 424, 10.7326/0003-4819-114-5-424
Miller MH, 1978, Antimicrob Agents Chemother, 14, 336, 10.1128/AAC.14.3.336
1982, Ann Intern Med, 97, 496, 10.7326/0003-4819-97-4-496
10.1016/S0140-6736(89)91083-0
10.1016/0002-9343(86)90180-4
Chambers HF, 1993, Infect Dis Clin North Am, 7, 69, 10.1016/S0891-5520(20)30506-7
Ribera E, 1996, Ann Intern Med, 125, 969, 10.7326/0003-4819-125-12-199612150-00005
10.1016/S0002-9343(96)00070-8
10.1016/0002-9343(90)90290-T
10.1016/0003-4975(94)90458-8
Reagan DR, 1991, Ann Intern Med, 114, 101, 10.7326/0003-4819-114-2-101
10.1016/0190-9622(90)70120-7
Fattom AI, 1996, Infect Immun, 64, 1659, 10.1128/IAI.64.5.1659-1665.1996
Lee JC, 1997, Infect Immun, 65, 4146, 10.1128/IAI.65.10.4146-4151.1997
10.1126/science.280.5362.438
1997, MMWR Morb Mortal Wkly Rep, 46, 626
Edmond MB, 1996, Ann Intern Med, 124, 329, 10.7326/0003-4819-124-3-199602010-00008